US FDA•United StatesCRL•Complete Response Letter
Complete Response Letter NDA 505b1 218317 (May 24, 2024)
Issued May 24, 2024
Issued
May 24, 2024
Application
NDA 505b1 • 218317
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
Response due May 24, 2025Requires resubmission addressing deficiencies.
Document viewer
Read the FDA letter and send context to the co-pilot at any time.